Меню
Идёт набор NCT05612022

Acoustic Analysis of VA Sounds

Наблюдательное End Stage Renal Disease Hemodialysis Access Failure

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: AVF creation, AVG creation.
Кому может быть актуально
Состояния в реестре: End Stage Renal Disease, Hemodialysis Access Failure. Базовые параметры: 18 лет — 90 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Италия
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Acoustic Analysis of Blood Flow-emitted Sounds to Detect Vascular Complications in Arteriovenous Fistulae and Grafts for Hemodialysis

Обзор

End-stage renal disease (ESRD) is a growing global health problem, strictly connected with progressive ageing population and longer survival of patients living on renal replacement therapy. The majority of ESRD patients is on hemodialysis (HD) treatment. A successful HD procedure requires a functioning vascular access (VA) to provide safe and long-lasting way to connect patient circulation to the artificial kidney. The current recommendation for VA is the native arteriovenous fistula (AVF), surgically created in the forearm by an anastomosis between a vein and an artery. The AVF, despite being the first-choice treatment, is still affected by high non-maturation and early failure rates, requiring in most of the cases, the creation of a new VA. An arteriovenous graft (AVG) is the second choice for a VA. Surgery is done using an artificial plastic tube that connects an artery to a vein. The AVG matures earlier than AVF (2/3 vs 6 weeks), but it is more prone to infections and has lower survival. It would be important to identify patients at risk of VA failure, but there is currently a lack of adequate strategies for surveillance. A continuous monitoring of the VA function would help in identification of reduced blood flow and VA stenosis, that could be treated by interventional radiologists before AVF or AVG complete closure. Over the years, nurses and nephrologists got used to touch the VA and qualitatively evaluate its vibration, named "thrill", and the sounds emitted by the same using their stethoscope. The purpose of this study is to assess the feasibility of VA sound recording and analysis and provide preliminary evidence of VA sound clinical validity and utility to assess, monitor and predict vascular remodelling occurring in AVFs and AVGs. This is a single center prospective observational study involving the acquisition of VA sounds and Doppler US examinations in consenting patients with ESRD. To reach this goal, two groups of ESRD patients in need of VA surgery to perform HD treatment will be involved: Group 1. Patients with AVF as first line HD access option. Group 2. Patients with AVG as first line HD access option.

Вмешательства

  • Процедура AVF creation
    AVF is surgically created in the forearm by an anastomosis between a vein and an artery
  • Процедура AVG creation
    Surgery is done using an artificial plastic tube that connects an artery to a vein

Первичные конечные точки

  • Low-high peak ratio (LHPR) [Срок оценки: From v3 (day 7) to end visit (month 24): change from previous visit]
Вторичные конечные точки (2)
  • Correlation coefficient between LHPR and Blood Flow Volume (BFV) during VA maturation. [Срок оценки: From v3 (day 7) to VA maturation (v6, day 42): change from previous visit]
  • Correlation coefficient between LHPR and Blood Flow Volume (BFV) after VA maturation. [Срок оценки: From v7 (day 60) to end visit (month 24): change from previous visit]

Критерии участия

Критерии включения

  • Provision of informed consent prior to any study specific procedures.
  • Patients in HD treatment that need a new VA or patients that entered the pre-dialysis program because of ESRD. In all these cases the treatment of first choice should be the creation of a distal autogenous AVF, the creation of an AVG or the proximalization of an occluded VA.

Критерии исключения

  • Contraindications for the creation of an autogenous AVF, for the AVG creation or the proximalization of a failed VA.
  • Patients who use catheter to perform HD.
  • Patients undergoing peritoneal dialysis.
  • Patients with life expectancy less than 2 years.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Модель наблюдения
Когортное

Центры проведения

Италия · 1 центр
  • ASST HPG23 Unità di Nefrologia e Dialisi — Bergamo

Идентификаторы

NCT: NCT05612022 · VAsound

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗